All Outputs (3)

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial (2021)
Journal Article
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., …Bafadhel, M. (2021). Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial. Lancet Respiratory Medicine, 9(7), 763-772. https://doi.org/10.1016/s2213-2600%2821%2900160-0

Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19 (2021)
Journal Article
Fadai, N. T., Sachak-Patwa, R., Byrne, H. M., Maini, P. K., Bafadhel, M., & Nicolau, D. V. (2021). Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19. Journal of the Royal Society, Interface, 18(175), Article 20200950. https://doi.org/10.1098/rsif.2020.0950

While the pathological mechanisms in COVID-19 illness are still poorly understood, it is increasingly clear that high levels of pro-inflammatory mediators play a major role in clinical deterioration in patients with severe disease. Current evidence p... Read More about Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19.

Semi-infinite travelling waves arising in a general reaction–diffusion Stefan model (2021)
Journal Article
Fadai, N. T. (2021). Semi-infinite travelling waves arising in a general reaction–diffusion Stefan model. Nonlinearity, 34(2), 725-743. https://doi.org/10.1088/1361-6544/abd07b